PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 39.92 USD -1.82% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
PTC Therapeutics Inc?
Write Note

PTC Therapeutics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PTC Therapeutics Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
PTC Therapeutics Inc
NASDAQ:PTCT
Revenue
$900.5m
CAGR 3-Years
24%
CAGR 5-Years
26%
CAGR 10-Years
40%
Abbvie Inc
NYSE:ABBV
Revenue
$55B
CAGR 3-Years
1%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.8B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Revenue
$30.9B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$10.3B
CAGR 3-Years
16%
CAGR 5-Years
25%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.5B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
18%

PTC Therapeutics Inc
Revenue Breakdown

Breakdown by Geography
PTC Therapeutics Inc

Total Revenue: 937.8m USD
100%
United States: 531.7m USD
56.7%
Non-Us: 406.2m USD
43.3%

Breakdown by Segments
PTC Therapeutics Inc

Not Available

See Also

What is PTC Therapeutics Inc's Revenue?
Revenue
900.5m USD

Based on the financial report for Jun 30, 2024, PTC Therapeutics Inc's Revenue amounts to 900.5m USD.

What is PTC Therapeutics Inc's Revenue growth rate?
Revenue CAGR 10Y
40%

Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for PTC Therapeutics Inc have been 24% over the past three years , 26% over the past five years , and 40% over the past ten years .

Back to Top